Systemic Juvenile Idiopathic Arthritis
3 competing products in clinical development for Systemic Juvenile Idiopathic Arthritis.
Pipeline by Phase
Phase 33
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| MRA(Tocilizumab) + placebo | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| MRA(Tocilizumab) | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| MRA(Tocilizumab) | Chugai Pharmaceutical | Phase 3 | Completed | 40 |